• Explore /
  • Poster
  • / A phase I dose-escalation study of an all-in-one 5-fluorouracil and leucovorin co-formulation administered after failure of standard treatment.

A phase I dose-escalation study of an all-in-one 5-fluorouracil and leucovorin co-formulation administered after failure of standard treatment.

Abstract Poster

Authors

null

Daniel Brungs

Cancer Care Wollongong, Wollongong, NSW, Australia

Daniel Brungs , Jonathon Hill , Morteza Aghmesheh , Stephen P. Ackland , Suzanne Parker , Rebecca Madeline Jokela , Madhu Bala Garg , Stephanie E. Reuter , Tahlia R. Meola , Marie Ranson , Richard David Ranson , Christian D. Toouli , Natalie Strange , Philip R. Clingan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

ACTRN12619001533189

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 140)

DOI

10.1200/JCO.2024.42.3_suppl.140

Abstract #

140

Poster Bd #

J6

Abstract Disclosures

Similar Posters

First Author: Koosha Paydary

First Author: Kanwal Pratap Singh Raghav

First Author: Krish Patel

First Author: Scott Kopetz